Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04014205
Title A Study of Tyrosine Kinase Inhibitor ICP-022 in Patients With r/r B-Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Beijing InnoCare Pharma Tech Co., Ltd.

marginal zone B-cell lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

follicular lymphoma

mantle cell lymphoma



Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.